Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Cash Flow
Transgene Biotek Ltd.
BSE Code 526139
ISIN Demat INE773D01018
Book Value (Rs) -0.89
NSE Code NA
Dividend Yield % 0.00
Market Cap(Rs Mn) 484.93
TTM PE(x) 0.00
TTM EPS(Rs) -0.03
Face Value (Rs) 10  
Type:
(Rs. in Million)
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax-6.56-60.08-104.02-104.35-109.62
Adjustment0.4649.5699.7699.99101.02
Changes In working Capital6.1410.535.244.4810.00
Cash Flow after changes in Working Capital0.050.000.980.131.39
Cash Flow from Operating Activities0.050.000.980.131.39
Cash Flow from Investing Activities0-0.12-0.97-0.270
Cash Flow from Financing Activities0000.00-2.00
Net Cash Inflow / Outflow0.05-0.120.01-0.15-0.61
Opening Cash & Cash Equivalents0.030.150.140.391.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger00000
Cash & Cash Equivalent of Subsidiaries under liquidations00000
Translation adjustment on reserves / op cash balalces frgn subsidiaries00000
Effect of Foreign Exchange Fluctuations00000
Closing Cash & Cash Equivalent0.080.030.150.240.39